SCHEMBL31255

SCHEMBL31255

Cc1cnc(C)nc1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15599294 0.83 NPC1 (0.37)
SCHEMBL10297764 0.78
SCHEMBL10021905 0.77 CCR1 (0.45)
SCHEMBL10021910 0.77 NPC1 (0.35)
SCHEMBL25036501 0.77 HTR2C (0.32)
SCHEMBL14129669 0.75 GRM5 (0.41)
SCHEMBL14129670 0.75 GRM5 (0.33)
SCHEMBL15599297 0.75 NPC1 (0.54)
SCHEMBL754165 0.72
SCHEMBL4436936 0.72

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Appears in 4714 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-119409918-A Application of organic framework material in electronic special gas adsorption storage and delivery 浙江大学 2025-02-11 CN claimed
CN-117624521-A Ionic covalent organic framework material, solid phase synthesis method and application thereof 耀科新材料(苏州)有限公司 2024-03-01 CN claimed
WO-2024037615-A1 IONIC COVALENT ORGANIC FRAMEWORK MATERIAL, SOLID-PHASE SYNTHESIS METHOD THEREOF, AND USE THEREOF 耀科新材料(天津)有限公司 2024-02-22 WO claimed
US-20230192657-A1 1,2,4-TRIAZOLINONE CB1 INHIBITORS GFB (ABC), LLC 2023-06-22 US claimed
EP-4114838-A1 1,2,4-TRIAZOLINONE CB1 INHIBITORS Goldfinch Bio, Inc. (US) 2023-01-11 EP claimed
CN-114929782-A Method for producing mixed polyamides, polyimides and polyamideimides by hydrothermal polymerization 埃克森美孚技术与工程公司 2022-08-19 CN claimed
US-20170056398-A1 SUBSTITUTED PYRIDINES AS P2X3 AND P2X2/3 ANTAGONISTS ROCHE PALO ALTO LLC (US) 2017-03-02 US claimed
US-20160362395-A1 INDOLE, INDAZOLE AND BENZIMIDAZOLE ARYLAMIDES AS P2X3 AND P2X2/3 ANTAGONISTS ROCHE PALO ALTO LLC (US) 2016-12-15 US claimed
US-9440956-B2 Indole, indazole and benzimidazole arylamides as P2X3 and P2X2/3 antagonists ROCHE PALO ALTO LLC (US) 2016-09-13 US claimed
EP-2445889-B1 NOVEL BENZOXAZOLONE -SUBSTITUTED ARYLAMIDES HOFFMANN LA ROCHE (CH) 2016-08-10 EP claimed
EP-2445889-A1 NOVEL OXAZOLONE AND PYRROLIDINONE-SUBSTITUTED ARYLAMIDES F. Hoffmann-La Roche AG (CH) 2012-05-02 EP claimed
EP-2445897-A1 NOVEL INDOLE, INDAZOLE AND BENZIMIDAZOLE ARYLAMIDES AS P2X3 AND/OR P2X2/3 ANTAGONISTS F. Hoffmann-La Roche AG (CH) 2012-05-02 EP claimed
US-20120083500-A1 OXAZOLONE AND PYRROLIDINONE-SUBSTITUTED ARYLAMIDES AS P2X3 AND P2X 2/3 ANTAGONISTS CHEN LI (CN) 2012-04-05 US claimed
US-8093275-B2 Oxazolone and pyrrolidinone-substituted pryidine amides as P2X3 and P2X2/3 antagonists ROCHE PALO ALTO LLC (US) 2012-01-10 US claimed
WO-2010149634-A1 NOVEL INDOLE, INDAZOLE AND BENZIMIDAZOLE ARYLAMIDES AS P2X3 AND/OR P2X2/3 ANTAGONISTS F. HOFFMANN-LA ROCHE AG (CH) 2010-12-29 WO claimed
WO-2010149541-A1 NOVEL OXAZOLONE AND PYRROLIDINONE-SUBSTITUTED ARYLAMIDES F. HOFFMANN-LA ROCHE AG (CH) 2010-12-29 WO claimed
US-20100324070-A1 INDOLE, INDAZOLE AND BENZIMIDAZOLE ARYLAMIDES AS P2X3 AND P2X2/3 ANTAGONISTS DILLON MICHAEL PATRICK 2010-12-23 US claimed
US-20100324069-A1 OXAZOLONE AND PYRROLIDINONE-SUBSTITUTED ARYLAMIDES AS P2X3 AND P2X2/3 ANTAGONISTS CHEN LI 2010-12-23 US claimed
US-4415566-A ANTIBIOTICS; BACTERIOSTATS; BACTERICIDES BOEHRINGER INGELHEIM GMBH (DE) 1983-11-15 US claimed
EP-0022494-B1 BETA-LACTAM-COMPOUNDS, PROCESS FOR THEIR PREPARATION AND THERAPEUTIC AGENTS CONTAINING THEM Dr. Karl Thomae GmbH (DE) 1983-02-23 EP claimed